Global Artemether Market Research Report 2024

Publication ID:

PB503248410

Publication Date:

March 13, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Artemether is a highly effective killing agent in erythrocyte phase of plasmodium. It is used in the treatment of chloroquine falciparum malaria and dangerous malaria.
The global Artemether market was valued at US$ 449 million in 2023 and is anticipated to reach US$ 666.9 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Artemether is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artemether is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artemether include KPC Pharmaceuticals, Shreeji Pharma International, HOFON, Guangzhou Hanfang Pharmaceutical and Ankang ChiaTai Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artemether, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemether.
Report Scope
The Artemether market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemether market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemether manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
KPC Pharmaceuticals
Shreeji Pharma International
HOFON
Guangzhou Hanfang Pharmaceutical
Ankang ChiaTai Pharmaceutical
Segment by Type
Injectables Artemether
Capsules Artemether
Tablets Artemether
Segment by Application
Hospital
Clinic
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemether manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artemether in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Artemether Market Overview
1.1 Product Overview and Scope of Artemether
1.2 Artemether Segment by Type
1.2.1 Global Artemether Market Value Comparison by Type (2024-2030)
1.2.2 Injectables Artemether
1.2.3 Capsules Artemether
1.2.4 Tablets Artemether
1.3 Artemether Segment by Application
1.3.1 Global Artemether Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Global Artemether Market Size Estimates and Forecasts
1.4.1 Global Artemether Revenue 2019-2030
1.4.2 Global Artemether Sales 2019-2030
1.4.3 Global Artemether Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artemether Market Competition by Manufacturers
2.1 Global Artemether Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artemether Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artemether Average Price by Manufacturers (2019-2024)
2.4 Global Artemether Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artemether, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artemether, Product Type & Application
2.7 Artemether Market Competitive Situation and Trends
2.7.1 Artemether Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artemether Players Market Share by Revenue
2.7.3 Global Artemether Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artemether Retrospective Market Scenario by Region
3.1 Global Artemether Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artemether Global Artemether Sales by Region: 2019-2030
3.2.1 Global Artemether Sales by Region: 2019-2024
3.2.2 Global Artemether Sales by Region: 2025-2030
3.3 Global Artemether Global Artemether Revenue by Region: 2019-2030
3.3.1 Global Artemether Revenue by Region: 2019-2024
3.3.2 Global Artemether Revenue by Region: 2025-2030
3.4 North America Artemether Market Facts & Figures by Country
3.4.1 North America Artemether Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artemether Sales by Country (2019-2030)
3.4.3 North America Artemether Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artemether Market Facts & Figures by Country
3.5.1 Europe Artemether Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artemether Sales by Country (2019-2030)
3.5.3 Europe Artemether Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artemether Market Facts & Figures by Country
3.6.1 Asia Pacific Artemether Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artemether Sales by Country (2019-2030)
3.6.3 Asia Pacific Artemether Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artemether Market Facts & Figures by Country
3.7.1 Latin America Artemether Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artemether Sales by Country (2019-2030)
3.7.3 Latin America Artemether Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artemether Market Facts & Figures by Country
3.8.1 Middle East and Africa Artemether Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artemether Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artemether Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artemether Sales by Type (2019-2030)
4.1.1 Global Artemether Sales by Type (2019-2024)
4.1.2 Global Artemether Sales by Type (2025-2030)
4.1.3 Global Artemether Sales Market Share by Type (2019-2030)
4.2 Global Artemether Revenue by Type (2019-2030)
4.2.1 Global Artemether Revenue by Type (2019-2024)
4.2.2 Global Artemether Revenue by Type (2025-2030)
4.2.3 Global Artemether Revenue Market Share by Type (2019-2030)
4.3 Global Artemether Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artemether Sales by Application (2019-2030)
5.1.1 Global Artemether Sales by Application (2019-2024)
5.1.2 Global Artemether Sales by Application (2025-2030)
5.1.3 Global Artemether Sales Market Share by Application (2019-2030)
5.2 Global Artemether Revenue by Application (2019-2030)
5.2.1 Global Artemether Revenue by Application (2019-2024)
5.2.2 Global Artemether Revenue by Application (2025-2030)
5.2.3 Global Artemether Revenue Market Share by Application (2019-2030)
5.3 Global Artemether Price by Application (2019-2030)
6 Key Companies Profiled
6.1 KPC Pharmaceuticals
6.1.1 KPC Pharmaceuticals Corporation Information
6.1.2 KPC Pharmaceuticals Description and Business Overview
6.1.3 KPC Pharmaceuticals Artemether Sales, Revenue and Gross Margin (2019-2024)
6.1.4 KPC Pharmaceuticals Artemether Product Portfolio
6.1.5 KPC Pharmaceuticals Recent Developments/Updates
6.2 Shreeji Pharma International
6.2.1 Shreeji Pharma International Corporation Information
6.2.2 Shreeji Pharma International Description and Business Overview
6.2.3 Shreeji Pharma International Artemether Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shreeji Pharma International Artemether Product Portfolio
6.2.5 Shreeji Pharma International Recent Developments/Updates
6.3 HOFON
6.3.1 HOFON Corporation Information
6.3.2 HOFON Description and Business Overview
6.3.3 HOFON Artemether Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HOFON Artemether Product Portfolio
6.3.5 HOFON Recent Developments/Updates
6.4 Guangzhou Hanfang Pharmaceutical
6.4.1 Guangzhou Hanfang Pharmaceutical Corporation Information
6.4.2 Guangzhou Hanfang Pharmaceutical Description and Business Overview
6.4.3 Guangzhou Hanfang Pharmaceutical Artemether Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangzhou Hanfang Pharmaceutical Artemether Product Portfolio
6.4.5 Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
6.5 Ankang ChiaTai Pharmaceutical
6.5.1 Ankang ChiaTai Pharmaceutical Corporation Information
6.5.2 Ankang ChiaTai Pharmaceutical Description and Business Overview
6.5.3 Ankang ChiaTai Pharmaceutical Artemether Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ankang ChiaTai Pharmaceutical Artemether Product Portfolio
6.5.5 Ankang ChiaTai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artemether Industry Chain Analysis
7.2 Artemether Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artemether Production Mode & Process
7.4 Artemether Sales and Marketing
7.4.1 Artemether Sales Channels
7.4.2 Artemether Distributors
7.5 Artemether Customers
8 Artemether Market Dynamics
8.1 Artemether Industry Trends
8.2 Artemether Market Drivers
8.3 Artemether Market Challenges
8.4 Artemether Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

KPC Pharmaceuticals
Shreeji Pharma International
HOFON
Guangzhou Hanfang Pharmaceutical
Ankang ChiaTai Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂